INS and type 1 diabetes mellitus: The Automated insulin Delivery Amongst Pregnant women with Type 1 diabetes (AiDAPT) trial provided landmark evidence supporting use of a uniquely adaptive HCL system (CamAPS FX) across a generalisable patient population [22].